ClinicalTrials.govpublic full text
Omega 3 Fish Oil Supplements vs. Placebo for Patients With Non-alcoholic Steatohepatitis (NASH)
non-alcoholic steatohepatitis, fatty liver, steatohepatitis, nash, nafld, omega 3 fatty acids, exercise conditioning, interventional, phase2, phase3
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 883412
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.